Part 2 Consents
On 12/21/2012, The largest U.S. supplier of diagnostic testing products used by small animal veterinarians, IDEXX Laboratories, Inc., agreed to drop its exclusive-dealing arrangements with a top distributor, resolving FTC charges that it was using the exclusive arrangements to stifle competition. IDEXX has agreed to a settlement order that prohibits concurrent exclusive distribution arrangements with the three national distributors of point-of-care (POC) diagnostic testing products. According to the FTC’s complaint, IDEXX has used its dominant market power to reduce competition by threatening to drop the distributors if they carried other companies’ products that compete with IDEXX products. On 02/12/2013, the FTC approved a final order settling charges that IDEXX Laboratories, Inc. acted anticompetitively by engaging in exclusive dealing arrangements with all three national distributors and two large regional distributors.